GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
Semaglutide linked to declines in intrahepatic triglycerides for people with HIV with metabolic-associated steatotic liver disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.